Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status

IMPORTANCE: Accurate blood-based biomarkers for Alzheimer disease (AD) might improve the diagnostic accuracy in primary care, referrals to memory clinics, and screenings for AD trials. OBJECTIVE: To examine the accuracy of plasma β-amyloid (Aβ) and tau measured using fully automated assays together...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Neurol
Main Authors: Palmqvist, Sebastian, Janelidze, Shorena, Stomrud, Erik, Zetterberg, Henrik, Karl, Johann, Zink, Katharina, Bittner, Tobias, Mattsson, Niklas, Eichenlaub, Udo, Blennow, Kaj, Hansson, Oskar
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6593637/
https://ncbi.nlm.nih.gov/pubmed/31233127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2019.1632
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados